APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rabies Antiserum

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rabies Antiserum Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchRabies Antiserum Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Antiserum Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Rabies Antiserum Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Antiserum Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Antiserum Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Rabies Antiserum market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rabies Antiserum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rabies Antiserum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rabies Antiserum is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rabies Antiserum market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rabies Antiserum market include Bharat Serums, Haffkine Bio-Pharmaceutical, Premium Serums, Lanzhou Institute of Biological Products, Serum China and Wuhan Institute of Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rabies Antiserum market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rabies Antiserum and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rabies Antiserum sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rabies Antiserum market size, projected growth trends, production technologies, key applications, and end-use industries.

Rabies Antiserum Segment by Company

Bharat Serums

Haffkine Bio-Pharmaceutical

Premium Serums

Lanzhou Institute of Biological Products

Serum China

Wuhan Institute of Biological Products

Rabies Antiserum Segment by Type

400IU

1500IU

1000IU

Other

Rabies Antiserum Segment by Application

Category II Exposure

Category III Exposure

Rabies Antiserum Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Rabies Antiserum status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rabies Antiserum market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rabies Antiserum significant trends, drivers, influence factors in global and regions.

6. To analyze Rabies Antiserum competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Antiserum market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Antiserum and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Antiserum.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rabies Antiserum market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rabies Antiserum industry.

Chapter 3: Detailed analysis of Rabies Antiserum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rabies Antiserum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rabies Antiserum in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rabies Antiserum Industry Trends Table 2. Rabies Antiserum Industry Drivers Table 3. Rabies Antiserum Industry Opportunities and Challenges Table 4. Rabies Antiserum Industry Restraints Table 5. Global Rabies Antiserum Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rabies Antiserum Revenue Share by Company (2021-2026) Table 7. Global Rabies Antiserum Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global Rabies Antiserum Sales Volume Share by Company (2021-2026) Table 9. Global Rabies Antiserum Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Rabies Antiserum Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rabies Antiserum Key Company Manufacturing Base & Headquarters Table 12. Global Rabies Antiserum Company, Product Type & Application Table 13. Global Rabies Antiserum Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rabies Antiserum by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 400IU Table 18. Significant Companies of 1500IU Table 19. Significant Companies of 1000IU Table 20. Significant Companies of Other Table 21. Global Rabies Antiserum Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 22. Global Rabies Antiserum Sales Volume by Type (2021-2026) & (K Tons) Table 23. Global Rabies Antiserum Sales Volume by Type (2027-2032) & (K Tons) Table 24. Global Rabies Antiserum Sales Volume Share by Type (2021-2026) Table 25. Global Rabies Antiserum Sales Volume Share by Type (2027-2032) Table 26. Global Rabies Antiserum Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rabies Antiserum Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Rabies Antiserum Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Rabies Antiserum Sales Value Share by Type (2021-2026) Table 30. Global Rabies Antiserum Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Category II Exposure Table 32. Significant Companies of Category III Exposure Table 33. Global Rabies Antiserum Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 34. Global Rabies Antiserum Sales Volume by Application (2021-2026) & (K Tons) Table 35. Global Rabies Antiserum Sales Volume by Application (2027-2032) & (K Tons) Table 36. Global Rabies Antiserum Sales Volume Share by Application (2021-2026) Table 37. Global Rabies Antiserum Sales Volume Share by Application (2027-2032) Table 38. Global Rabies Antiserum Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Rabies Antiserum Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Rabies Antiserum Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Rabies Antiserum Sales Value Share by Application (2021-2026) Table 42. Global Rabies Antiserum Sales Value Share by Application (2027-2032) Table 43. Global Rabies Antiserum Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 44. Global Rabies Antiserum Sales by Region (2021-2026) & (K Tons) Table 45. Global Rabies Antiserum Sales Market Share by Region (2021-2026) Table 46. Global Rabies Antiserum Sales by Region (2027-2032) & (K Tons) Table 47. Global Rabies Antiserum Sales Market Share by Region (2027-2032) Table 48. Global Rabies Antiserum Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Rabies Antiserum Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Rabies Antiserum Sales Value Share by Region (2021-2026) Table 51. Global Rabies Antiserum Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Rabies Antiserum Sales Value Share by Region (2027-2032) Table 53. Global Rabies Antiserum Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Rabies Antiserum Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Rabies Antiserum Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Global Rabies Antiserum Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Rabies Antiserum Sales by Country (2021-2026) & (K Tons) Table 58. Global Rabies Antiserum Sales Market Share by Country (2021-2026) Table 59. Global Rabies Antiserum Sales by Country (2027-2032) & (K Tons) Table 60. Global Rabies Antiserum Sales Market Share by Country (2027-2032) Table 61. Global Rabies Antiserum Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Rabies Antiserum Sales Value Market Share by Country (2021-2026) Table 63. Global Rabies Antiserum Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Rabies Antiserum Sales Value Market Share by Country (2027-2032) Table 65. Bharat Serums Company Information Table 66. Bharat Serums Business Overview Table 67. Bharat Serums Rabies Antiserum Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Bharat Serums Rabies Antiserum Product Portfolio Table 69. Bharat Serums Recent Development Table 70. Haffkine Bio-Pharmaceutical Company Information Table 71. Haffkine Bio-Pharmaceutical Business Overview Table 72. Haffkine Bio-Pharmaceutical Rabies Antiserum Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Haffkine Bio-Pharmaceutical Rabies Antiserum Product Portfolio Table 74. Haffkine Bio-Pharmaceutical Recent Development Table 75. Premium Serums Company Information Table 76. Premium Serums Business Overview Table 77. Premium Serums Rabies Antiserum Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Premium Serums Rabies Antiserum Product Portfolio Table 79. Premium Serums Recent Development Table 80. Lanzhou Institute of Biological Products Company Information Table 81. Lanzhou Institute of Biological Products Business Overview Table 82. Lanzhou Institute of Biological Products Rabies Antiserum Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Lanzhou Institute of Biological Products Rabies Antiserum Product Portfolio Table 84. Lanzhou Institute of Biological Products Recent Development Table 85. Serum China Company Information Table 86. Serum China Business Overview Table 87. Serum China Rabies Antiserum Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Serum China Rabies Antiserum Product Portfolio Table 89. Serum China Recent Development Table 90. Wuhan Institute of Biological Products Company Information Table 91. Wuhan Institute of Biological Products Business Overview Table 92. Wuhan Institute of Biological Products Rabies Antiserum Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Wuhan Institute of Biological Products Rabies Antiserum Product Portfolio Table 94. Wuhan Institute of Biological Products Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Rabies Antiserum Distributors List Table 98. Rabies Antiserum Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Rabies Antiserum Product Image Figure 2. Global Rabies Antiserum Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Antiserum Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rabies Antiserum Sales (2021-2032) & (K Tons) Figure 5. Global Rabies Antiserum Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Rabies Antiserum Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 400IU Image Figure 10. 1500IU Image Figure 11. 1000IU Image Figure 12. Other Image Figure 13. Global Rabies Antiserum Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 14. Global Rabies Antiserum Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Rabies Antiserum Sales Volume Share by Type (2021-2032) Figure 16. Global Rabies Antiserum Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rabies Antiserum Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Rabies Antiserum Sales Value Share by Type (2021-2032) Figure 19. Category II Exposure Image Figure 20. Category III Exposure Image Figure 21. Global Rabies Antiserum Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 22. Global Rabies Antiserum Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Rabies Antiserum Sales Volume Share by Application (2021-2032) Figure 24. Global Rabies Antiserum Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Rabies Antiserum Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Rabies Antiserum Sales Value Share by Application (2021-2032) Figure 27. Global Rabies Antiserum Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 28. Global Rabies Antiserum Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Rabies Antiserum Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Rabies Antiserum Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Rabies Antiserum Sales Value (2021-2032) & (US$ Million) Figure 32. North America Rabies Antiserum Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Rabies Antiserum Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Rabies Antiserum Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Rabies Antiserum Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Rabies Antiserum Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Rabies Antiserum Sales Value (2021-2032) & (US$ Million) Figure 38. South America Rabies Antiserum Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Rabies Antiserum Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Rabies Antiserum Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Rabies Antiserum Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Rabies Antiserum Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Rabies Antiserum Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Rabies Antiserum Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Rabies Antiserum Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 400IU
  • 1500IU
  • 1000IU
  • Other
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Bharat Serums
  • Haffkine Bio-Pharmaceutical
  • Premium Serums
  • Lanzhou Institute of Biological Products
  • Serum China
  • Wuhan Institute of Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rabies Antiserum Sales Value (2021-2032)
  4. 1.2.2 Global Rabies Antiserum Sales Volume (2021-2032)
  5. 1.2.3 Global Rabies Antiserum Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rabies Antiserum Market Dynamics
  1. 2.1 Rabies Antiserum Industry Trends
  2. 2.2 Rabies Antiserum Industry Drivers
  3. 2.3 Rabies Antiserum Industry Opportunities and Challenges
  4. 2.4 Rabies Antiserum Industry Restraints
3 Rabies Antiserum Market by Company
  1. 3.1 Global Rabies Antiserum Company Revenue Ranking in 2025
  2. 3.2 Global Rabies Antiserum Revenue by Company (2021-2026)
  3. 3.3 Global Rabies Antiserum Sales Volume by Company (2021-2026)
  4. 3.4 Global Rabies Antiserum Average Price by Company (2021-2026)
  5. 3.5 Global Rabies Antiserum Company Ranking (2024-2026)
  6. 3.6 Global Rabies Antiserum Company Manufacturing Base and Headquarters
  7. 3.7 Global Rabies Antiserum Company Product Type and Application
  8. 3.8 Global Rabies Antiserum Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rabies Antiserum Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rabies Antiserum Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rabies Antiserum Market by Type
  1. 4.1 Rabies Antiserum Type Introduction
  2. 4.1.1 400IU
  3. 4.1.2 1500IU
  4. 4.1.3 1000IU
  5. 4.1.4 Other
  6. 4.2 Global Rabies Antiserum Sales Volume by Type
  7. 4.2.1 Global Rabies Antiserum Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Rabies Antiserum Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Rabies Antiserum Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Rabies Antiserum Sales Value by Type
  11. 4.3.1 Global Rabies Antiserum Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Rabies Antiserum Sales Value by Type (2021-2032)
  13. 4.3.3 Global Rabies Antiserum Sales Value Share by Type (2021-2032)
5 Rabies Antiserum Market by Application
  1. 5.1 Rabies Antiserum Application Introduction
  2. 5.1.1 Category II Exposure
  3. 5.1.2 Category III Exposure
  4. 5.2 Global Rabies Antiserum Sales Volume by Application
  5. 5.2.1 Global Rabies Antiserum Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Rabies Antiserum Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Rabies Antiserum Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Rabies Antiserum Sales Value by Application
  9. 5.3.1 Global Rabies Antiserum Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Rabies Antiserum Sales Value by Application (2021-2032)
  11. 5.3.3 Global Rabies Antiserum Sales Value Share by Application (2021-2032)
6 Rabies Antiserum Regional Sales and Value Analysis
  1. 6.1 Global Rabies Antiserum Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rabies Antiserum Sales by Region (2021-2032)
  3. 6.2.1 Global Rabies Antiserum Sales by Region: 2021-2026
  4. 6.2.2 Global Rabies Antiserum Sales by Region (2027-2032)
  5. 6.3 Global Rabies Antiserum Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rabies Antiserum Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rabies Antiserum Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rabies Antiserum Sales Value by Region (2027-2032)
  9. 6.5 Global Rabies Antiserum Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rabies Antiserum Sales Value (2021-2032)
  12. 6.6.2 North America Rabies Antiserum Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rabies Antiserum Sales Value (2021-2032)
  15. 6.7.2 Europe Rabies Antiserum Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rabies Antiserum Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rabies Antiserum Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rabies Antiserum Sales Value (2021-2032)
  21. 6.9.2 South America Rabies Antiserum Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rabies Antiserum Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rabies Antiserum Sales Value Share by Country, 2025 VS 2032
7 Rabies Antiserum Country-level Sales and Value Analysis
  1. 7.1 Global Rabies Antiserum Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rabies Antiserum Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rabies Antiserum Sales by Country (2021-2032)
  4. 7.3.1 Global Rabies Antiserum Sales by Country (2021-2026)
  5. 7.3.2 Global Rabies Antiserum Sales by Country (2027-2032)
  6. 7.4 Global Rabies Antiserum Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rabies Antiserum Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rabies Antiserum Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rabies Antiserum Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rabies Antiserum Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rabies Antiserum Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rabies Antiserum Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rabies Antiserum Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rabies Antiserum Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rabies Antiserum Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rabies Antiserum Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rabies Antiserum Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rabies Antiserum Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rabies Antiserum Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rabies Antiserum Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rabies Antiserum Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rabies Antiserum Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rabies Antiserum Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rabies Antiserum Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rabies Antiserum Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rabies Antiserum Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rabies Antiserum Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rabies Antiserum Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rabies Antiserum Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rabies Antiserum Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rabies Antiserum Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rabies Antiserum Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rabies Antiserum Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rabies Antiserum Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rabies Antiserum Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rabies Antiserum Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rabies Antiserum Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rabies Antiserum Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Serums
  2. 8.1.1 Bharat Serums Company Information
  3. 8.1.2 Bharat Serums Business Overview
  4. 8.1.3 Bharat Serums Rabies Antiserum Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Serums Rabies Antiserum Product Portfolio
  6. 8.1.5 Bharat Serums Recent Developments
  7. 8.2 Haffkine Bio-Pharmaceutical
  8. 8.2.1 Haffkine Bio-Pharmaceutical Company Information
  9. 8.2.2 Haffkine Bio-Pharmaceutical Business Overview
  10. 8.2.3 Haffkine Bio-Pharmaceutical Rabies Antiserum Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Haffkine Bio-Pharmaceutical Rabies Antiserum Product Portfolio
  12. 8.2.5 Haffkine Bio-Pharmaceutical Recent Developments
  13. 8.3 Premium Serums
  14. 8.3.1 Premium Serums Company Information
  15. 8.3.2 Premium Serums Business Overview
  16. 8.3.3 Premium Serums Rabies Antiserum Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Premium Serums Rabies Antiserum Product Portfolio
  18. 8.3.5 Premium Serums Recent Developments
  19. 8.4 Lanzhou Institute of Biological Products
  20. 8.4.1 Lanzhou Institute of Biological Products Company Information
  21. 8.4.2 Lanzhou Institute of Biological Products Business Overview
  22. 8.4.3 Lanzhou Institute of Biological Products Rabies Antiserum Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lanzhou Institute of Biological Products Rabies Antiserum Product Portfolio
  24. 8.4.5 Lanzhou Institute of Biological Products Recent Developments
  25. 8.5 Serum China
  26. 8.5.1 Serum China Company Information
  27. 8.5.2 Serum China Business Overview
  28. 8.5.3 Serum China Rabies Antiserum Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Serum China Rabies Antiserum Product Portfolio
  30. 8.5.5 Serum China Recent Developments
  31. 8.6 Wuhan Institute of Biological Products
  32. 8.6.1 Wuhan Institute of Biological Products Company Information
  33. 8.6.2 Wuhan Institute of Biological Products Business Overview
  34. 8.6.3 Wuhan Institute of Biological Products Rabies Antiserum Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Wuhan Institute of Biological Products Rabies Antiserum Product Portfolio
  36. 8.6.5 Wuhan Institute of Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rabies Antiserum Value Chain Analysis
  2. 9.1.1 Rabies Antiserum Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rabies Antiserum Sales Mode & Process
  6. 9.2 Rabies Antiserum Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rabies Antiserum Distributors
  9. 9.2.3 Rabies Antiserum Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst